Our structure

Our work is focused on five areas covering public affairs, regulatory affairs, influenza, access to vaccines, and research and development.

Executive board

Sue

Middleton

President (GSK Vaccines)

Florence

Baron-Papillon

Vice - President (Sanofi Pasteur)

Andreas

Potthoff

(Abbott)

Hans

Sijbesma

(AstraZeneca)

Nicoletta

Luppi

(MSD)

Sharon

McHale

(Seqirus)

Jurgen

Kwik

(Janssen/JnJ)

Cornelia

Oostvogels

(Curevac)

Logan

Rae

(Takeda)

Sinan

Atlig

Treasurer (Pfizer)

Executive office

Sibilia

Quilici

Executive Director

Laurent

Louette

Director, Public Affairs and Market Access

Anna

Czwarno

Director, Regulatory and R&D

Anna

Vicere

Senior Manager, Government Affairs and Policy (on maternity leave)

Polina

Zoveta

Communication Lead (on maternity leave)

Anne

Meynaerts

Administrative Assistant

Working Group Chairs

Research, Innovation & Medical

Manufacturing & Supply

Philippe

Juvin

Sanofi

National Vaccine Industry Group's Task Force

Renée

Gallo-Daniel

Pfizer